Janssen’s Invega Hayfera is the first six-month injectable schizophrenia treatment approved by FDA. Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced that FDA approved their long-acting atypical antipsychotic Invega Hayfera (six-month paliperidone palmitate) for treatment of schizophrenia in adults. Paliperidone palmitate is the first twice-yearly i ...
Janssen’s Invega Hayfera is the first six-month injectable schizophrenia treatment approved by FDA. Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced that FDA approved their long-acting atypical antipsychotic Invega Hayfera (six-month paliperidone pal ...
fkljghajdfhg;kauhdfsg;iuhaiurghpiuawehdg;kuahs;dkughnfaiusrhgpiquwher... View More
;osdknfgpoiwdhgpiuhqe0irugh0qeuhrgt0iuqher0g... View More
dfliugAEIFYGoygefiyugIEWFYEFGYpiqef... View More